Kai Wang - HOB Biotech Board GM
| 688656 Stock | 107.02 4.43 3.97% |
Executive
Kai Wang is Board GM of HOB Biotech Group
| Age | 60 |
| Address | Building C6 and C10, Suzhou, China, 215123 |
| Phone | 86 512 6956 1996 |
| Web | https://www.hobiotech.com |
HOB Biotech Management Efficiency
The company has return on total asset (ROA) of 0.0266 % which means that it generated a profit of $0.0266 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0439 %, meaning that it generated $0.0439 on every $100 dollars invested by stockholders. HOB Biotech's management efficiency ratios could be used to measure how well HOB Biotech manages its routine affairs as well as how well it operates its assets and liabilities. At present, HOB Biotech's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 16.5 M, whereas Total Assets are forecasted to decline to about 526.8 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Chongmiao Xu | China Life Insurance | 55 | |
| Liurong Sheng | China Construction Bank | 59 | |
| Chengwen Zhuo | Bank of China | 54 | |
| Jianhua Song | Industrial and Commercial | 59 | |
| Lee Woo | Agricultural Bank of | N/A | |
| Guoli Tian | China Construction Bank | 64 | |
| Yuanguo Cheng | China Construction Bank | 61 | |
| Jianjiang Li | China Construction Bank | 51 | |
| Yan Xiong | Industrial and Commercial | 60 | |
| Li Jiang | Contemporary Amperex Technology | 45 | |
| Mingde Yao | Agricultural Bank of | 54 | |
| Zou Xin | Industrial and Commercial | N/A | |
| Jin Hou | China Life Insurance | 44 | |
| Changmiao Hu | China Construction Bank | 60 | |
| Libin Tan | Contemporary Amperex Technology | 56 | |
| Panshi Jin | China Construction Bank | 59 | |
| Li Huang | Industrial and Commercial | 60 | |
| Yuejin Liu | China Life Insurance | 57 | |
| Siqing Chen | Industrial and Commercial | 64 | |
| Weisheng Yang | PetroChina Co Ltd | 51 | |
| Bresson Xu | Industrial and Commercial | N/A | |
Management Performance
| Return On Equity | 0.0439 | ||||
| Return On Asset | 0.0266 |
HOB Biotech Group Leadership Team
Elected by the shareholders, the HOB Biotech's board of directors comprises two types of representatives: HOB Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HOB. The board's role is to monitor HOB Biotech's management team and ensure that shareholders' interests are well served. HOB Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HOB Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Xiaohua Huang, Deputy Manager | ||
| John Li, Chairman GM | ||
| Ruoliang Sun, Deputy Manager | ||
| Qingxin Liu, Director GM | ||
| Shuyan Han, Chief Officer | ||
| Aixiang Xie, Secretary | ||
| Yi Li, Financial Manager | ||
| Kai Wang, Board GM | ||
| Jerry Li, Chief Officer |
HOB Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is HOB Biotech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0439 | ||||
| Return On Asset | 0.0266 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 7.03 B | ||||
| Shares Outstanding | 63.06 M | ||||
| Shares Owned By Insiders | 77.69 % | ||||
| Shares Owned By Institutions | 3.10 % | ||||
| Price To Book | 8.72 X | ||||
| Price To Sales | 16.82 X |
Currently Active Assets on Macroaxis
Other Information on Investing in HOB Stock
HOB Biotech financial ratios help investors to determine whether HOB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HOB with respect to the benefits of owning HOB Biotech security.